Leawood, KSNCT07866131Now EnrollingIRB Ready

Acne-prone Skin Clinical Trial in Leawood, KS

Access cutting-edge acne-prone skin treatment through this clinical trial at a research site in Leawood. Study-provided care at no cost to qualified participants.

Sponsored by WiQo S.p.A.

Quick Self-Assessment

See if you qualify for this Leawood location

Preparing your pre-screening questions…

Expert Care in Leawood

Access acne-prone skin specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related acne-prone skin treatment provided free

Apply for This Leawood Location

Check if you qualify for this acne-prone skin clinical trial in Leawood, KS

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Leawood

    Convenient for KS residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Leawood site if eligible
  4. 4Begin participation

About This Acne-prone Skin Study in Leawood

This pilot cohort study evaluates changes in skin surface appearance in adult participants with acne-prone skin during and following a standardized five-session course of PRX S (WiQo SpA), a topical cosmetic product designed for oily and acne-prone skin. The study asks whether a standardized in-office PRX S treatment cycle - five sessions administered at two-week intervals and complemented by a prescribed home care regimen - is associated with observable changes in objective skin surface parameters (pore appearance, texture, spots, redness, porphyrins), clinician-rated acne severity (IGA, GAGS), and participant-reported skin-related quality of life (QoL-RA) in adults with acne-prone skin. Using a single-group, pre-post observational design across two U.S. sites (Leawood, KS and Tulsa, OK), 30 participants will undergo VISIA complexion analysis and clinical assessments at baseline (T0), mid-cycle (T1, Week 6), and end of follow-up (T2, Week 10). No single primary endpoint is designated; all analyses are explicitly exploratory.

Sponsor: WiQo S.p.A.

Who Can Participate

Inclusion Criteria

Age 18 years or older at the time of informed consent.
Presence of acne-prone skin characteristics defined as an IGA score of 1 (almost clear) to 3 (moderate) at baseline (T0).
Willing and able to commit to 5 in-office treatment sessions at approximately 2-week intervals over approximately 8 weeks, plus one follow-up visit at Week 10.
Willing to discontinue all current skincare products and adhere exclusively to the WiQo standardized home care regimen throughout the study period. The participant's current skincare regimen must be, in the investigator's judgment, safe to discontinue on the day of the first treatment session without requiring a prior washout period.
Able to understand and willing to sign the informed consent form prior to any study procedure.
In general good health as determined by medical history and investigator judgment.
Ability to read and understand English at a level sufficient to provide written informed consent and complete all study questionnaires independently.

Exclusion Criteria

IGA score of 0 (clear) or 4 (severe) at baseline.
Active skin infection, open wounds, or acute inflammatory dermatological conditions in the facial treatment area at the time of enrollment.
History of hypersensitivity or known allergy to any component of the PRX S formulation or the WiQo home care products.
Use of systemic retinoids within 6 months prior to enrollment.
Use of systemic antibiotics for acne within 4 weeks prior to enrollment.
Ongoing use of topical prescription acne medications (retinoids, topical antibiotics, dapsone) that the participant is unwilling or unable to discontinue.
Pregnancy, breastfeeding, or planned pregnancy during the study period. Pregnancy status is determined by participant self-report at screening and confirmed through the signed Informed Consent Form, in which the participant acknowledges that pregnancy constitutes a contraindication to the study treatment.
Prior cosmetic or aesthetic treatment of the face (chemical peel, laser, microneedling, injectables) within 4 weeks prior to enrollment, or prior treatment of the chest or back within 4 weeks prior to enrollment that, in the investigator's judgment, could confound GAGS assessments.
Any active medical condition that, in the investigator's judgment, could confound study assessments or place the participant at undue risk.
Participation in another interventional clinical study within 30 days prior to enrollment.
Inability or unwillingness to comply with study procedures and follow-up requirements.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Leawood?

Yes, this clinical trial (NCT07866131) has an active research site in Leawood, KS that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Acne-prone Skin Treatment Options in Leawood, KS

If you're searching for acne-prone skin treatment options in Leawood, KS, this clinical trial (NCT07866131) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Leawood research site is actively enrolling participants for this clinical trial. You'll receive care from experienced acne-prone skin specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all acne-prone skin clinical trials near you to find additional studies recruiting in your area.

More Acne Trials in Leawood, KS

See all acne clinical trials recruiting in Leawood — not just this study.

Browse Acne Trials in Leawood →

Browse More Trials by Condition

Acne TrialsAll Conditions →

Ready to Join in Leawood?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Leawood, KS